Cas no 1219803-46-9 (3-METHYLBUTYRYL-D9 CHLORIDE)
3-METHYLBUTYRYL-D9 CHLORIDE Chemical and Physical Properties
Names and Identifiers
-
- 3-Methylbutyryl-d9?Chloride
- 3-METHYLBUTYRYL-D9 CHLORIDE
-
- Inchi: 1S/C5H9ClO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3
- InChI Key: ISULZYQDGYXDFW-UHFFFAOYSA-N
- SMILES: C([H])([H])(C(=O)Cl)C([H])(C([H])([H])[H])C([H])([H])[H]
3-METHYLBUTYRYL-D9 CHLORIDE Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | I917592-2.5mg |
3-?Methylbutyryl-?d9 Chloride |
1219803-46-9 | 2.5mg |
$ 236.00 | 2023-09-07 | ||
| TRC | I917592-5mg |
3-?Methylbutyryl-?d9 Chloride |
1219803-46-9 | 5mg |
$ 437.00 | 2023-09-07 | ||
| TRC | I917592-10mg |
3-?Methylbutyryl-?d9 Chloride |
1219803-46-9 | 10mg |
$ 839.00 | 2023-09-07 | ||
| TRC | I917592-25mg |
3-?Methylbutyryl-?d9 Chloride |
1219803-46-9 | 25mg |
$1786.00 | 2023-05-18 |
3-METHYLBUTYRYL-D9 CHLORIDE Related Literature
-
Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
-
Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
Additional information on 3-METHYLBUTYRYL-D9 CHLORIDE
Introduction to 3-METHYLBUTYRYL-D9 CHLORIDE (CAS No. 1219803-46-9)
3-METHYLBUTYRYL-D9 CHLORIDE, with the CAS number 1219803-46-9, is a deuterated derivative of 3-methylbutyryl chloride. This compound is of significant interest in the fields of organic synthesis, pharmaceutical research, and analytical chemistry due to its unique properties and applications. Deuterated compounds, such as 3-METHYLBUTYRYL-D9 CHLORIDE, are valuable tools in the study of reaction mechanisms, metabolic pathways, and the development of stable isotope-labeled standards for mass spectrometry.
The chemical structure of 3-METHYLBUTYRYL-D9 CHLORIDE consists of a 3-methylbutyryl group with all hydrogen atoms replaced by deuterium atoms, and a chlorine atom attached to the carbonyl carbon. This deuterium labeling provides enhanced stability and distinct spectroscopic properties, making it an ideal reagent for various analytical techniques. The compound is typically synthesized through the deuteration of 3-methylbutyryl chloride using deuterium gas or deuterated solvents.
In recent years, the use of deuterated compounds has gained significant traction in pharmaceutical research. One notable application is in the development of stable isotope-labeled internal standards for quantitative analysis. These standards are crucial for ensuring the accuracy and reliability of analytical methods used in drug metabolism studies, pharmacokinetic evaluations, and clinical trials. For instance, a study published in the Journal of Pharmaceutical and Biomedical Analysis demonstrated the utility of deuterated compounds like 3-METHYLBUTYRYL-D9 CHLORIDE in improving the precision and sensitivity of liquid chromatography-mass spectrometry (LC-MS) assays.
Beyond its role as an analytical standard, 3-METHYLBUTYRYL-D9 CHLORIDE has also found applications in organic synthesis. The deuterium labeling can help elucidate reaction mechanisms by tracing the fate of specific atoms during chemical transformations. This information is invaluable for optimizing synthetic routes and understanding side reactions. A recent publication in the Tetrahedron Letters highlighted the use of deuterated reagents in probing the stereochemistry and regioselectivity of carbonyl addition reactions.
In the context of drug discovery, deuterated compounds can be used to study metabolic stability and bioavailability. By replacing hydrogen atoms with deuterium, researchers can create analogs that exhibit altered metabolic profiles compared to their non-deuterated counterparts. This approach has been explored in several preclinical studies to identify potential drug candidates with improved pharmacological properties. For example, a study published in the European Journal of Medicinal Chemistry reported that deuterated derivatives of certain drugs showed enhanced metabolic stability and reduced toxicity.
The synthesis and characterization of 3-METHYLBUTYRYL-D9 CHLORIDE involve well-established methodologies in organic chemistry. Typically, the compound is prepared by reacting 3-methylbutyryl chloride with a suitable deuterating agent under controlled conditions. The resulting product is then purified using techniques such as distillation or column chromatography to ensure high purity and isotopic enrichment. Spectroscopic methods, including nuclear magnetic resonance (NMR) and mass spectrometry (MS), are employed to confirm the structure and isotopic composition.
In summary, 3-METHYLBUTYRYL-D9 CHLORIDE (CAS No. 1219803-46-9) is a versatile compound with a wide range of applications in organic synthesis, pharmaceutical research, and analytical chemistry. Its unique properties make it an indispensable tool for advancing our understanding of chemical reactions and developing more accurate analytical methods. As research continues to evolve, it is likely that new applications for this compound will be discovered, further solidifying its importance in these fields.
1219803-46-9 (3-METHYLBUTYRYL-D9 CHLORIDE) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)